Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient

Immunodeficient patients are at risk of developing extended or atypical herpes simplex virus infections, which can be easily misdiagnosed. We present the case of a 79-year-old, treatment-induced (oral corticosteroid), immunocompromised female with an extensive atypical herpes simplex virus infection...

Full description

Bibliographic Details
Main Authors: Anne L.Y. Lecluse, Carla A.F.M. Bruijnzeel-Koomen
Format: Article
Language:English
Published: Karger Publishers 2010-06-01
Series:Case Reports in Dermatology
Subjects:
Online Access:http://www.karger.com/Article/FullText/315352
id doaj-0388d59a6efd4e52b40a2e54e43aa067
record_format Article
spelling doaj-0388d59a6efd4e52b40a2e54e43aa0672020-11-24T23:15:40ZengKarger PublishersCase Reports in Dermatology1662-65672010-06-01229910210.1159/000315352315352Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised PatientAnne L.Y. LecluseCarla A.F.M. Bruijnzeel-KoomenImmunodeficient patients are at risk of developing extended or atypical herpes simplex virus infections, which can be easily misdiagnosed. We present the case of a 79-year-old, treatment-induced (oral corticosteroid), immunocompromised female with an extensive atypical herpes simplex virus infection. This patient presented with multiple erosions and vesicles on the trunk with a subacute onset. The clinical differential diagnosis was herpes simplex infection, herpes zoster infection, pemphigus vulgaris or bullous pemphigoid. Due to the atypical clinical presentation and negative Tzanck test, suspicion of viral infection was low. High-dose steroid treatment was initiated. Subsequent histopathology, however, showed a herpes simplex virus infection. After discontinuing steroid treatment and initiating antiviral treatment, the patient recovered within a week. Emphasis must be placed on the importance of clinical awareness of extended and clinically atypical herpes simplex infections in immunocompromised patients. A negative Tzanck test does not rule out the possibility of a herpes infection.http://www.karger.com/Article/FullText/315352Tzanck testHerpes simplex infectionHerpes simplex virusImmunosuppression
collection DOAJ
language English
format Article
sources DOAJ
author Anne L.Y. Lecluse
Carla A.F.M. Bruijnzeel-Koomen
spellingShingle Anne L.Y. Lecluse
Carla A.F.M. Bruijnzeel-Koomen
Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
Case Reports in Dermatology
Tzanck test
Herpes simplex infection
Herpes simplex virus
Immunosuppression
author_facet Anne L.Y. Lecluse
Carla A.F.M. Bruijnzeel-Koomen
author_sort Anne L.Y. Lecluse
title Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
title_short Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
title_full Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
title_fullStr Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
title_full_unstemmed Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
title_sort herpes simplex virus infection mimicking bullous disease in an immunocompromised patient
publisher Karger Publishers
series Case Reports in Dermatology
issn 1662-6567
publishDate 2010-06-01
description Immunodeficient patients are at risk of developing extended or atypical herpes simplex virus infections, which can be easily misdiagnosed. We present the case of a 79-year-old, treatment-induced (oral corticosteroid), immunocompromised female with an extensive atypical herpes simplex virus infection. This patient presented with multiple erosions and vesicles on the trunk with a subacute onset. The clinical differential diagnosis was herpes simplex infection, herpes zoster infection, pemphigus vulgaris or bullous pemphigoid. Due to the atypical clinical presentation and negative Tzanck test, suspicion of viral infection was low. High-dose steroid treatment was initiated. Subsequent histopathology, however, showed a herpes simplex virus infection. After discontinuing steroid treatment and initiating antiviral treatment, the patient recovered within a week. Emphasis must be placed on the importance of clinical awareness of extended and clinically atypical herpes simplex infections in immunocompromised patients. A negative Tzanck test does not rule out the possibility of a herpes infection.
topic Tzanck test
Herpes simplex infection
Herpes simplex virus
Immunosuppression
url http://www.karger.com/Article/FullText/315352
work_keys_str_mv AT annelylecluse herpessimplexvirusinfectionmimickingbullousdiseaseinanimmunocompromisedpatient
AT carlaafmbruijnzeelkoomen herpessimplexvirusinfectionmimickingbullousdiseaseinanimmunocompromisedpatient
_version_ 1725589841552343040